Impending Patent Losses Creating Eli Lilly Uncertainty

Impending Patent Losses Creating Eli Lilly Uncertainty

Filed under: drug treatment news articles

For one, Eli Lilly's blockbuster drug Cymbalta, generated record sales of $ 2.3 billion in the first six months of 2012. In the second quarter, Cymbalta's year-over-year sales increased by 22%. Eli Lilly also has a new diabetes treatment in its pipeline.
Read more on Seeking Alpha

PropThink: Management says Ariad is Well-Prepared for Ponatinib Launch

Filed under: drug treatment news articles

Pending ponatinib's approval for treatment of resistant or intolerant chronic myeloid leukemia (CML), Ariad believes they are fully prepared for a U.S. commercialization (PDUFA slated for March 27, 2013), and efforts are underway in the E.U. to …
Read more on Reuters

Connecting Patients With Experimental Drugs

Filed under: drug treatment news articles

Last year, nearly 1,200 patients received treatment with experimental drugs through the compassionate-use program for conditions including hepatitis C, cancer and rare diseases like cystic fibrosis, the FDA says. That is up from about 1,000 patients in …
Read more on Wall Street Journal